While biochemistry evidently affects the growth rate of cells, many biochemists routinely ignore population variation, just like population geneticists usually ignore causal details of biochemistry that underpin a change in growth rate caused by a mutation. A true EvoSysBio integration requires an explicit mechanism for how molecular reaction rates affect the reproduction rates that determine the fitness of an organism. Here we simulate a very simple and completely explicit Continuous-Time Markov Chain (CTMC) model of cancer cells whose growth rate is affected by the biochemical equilibrium between two molecular complexes. Approximately 70% of breast cancers are of a type that overexpress Estrogen Receptor-alpha (ERα). Cell growth in this type of cancer is inhibited by hormonal therapies that antagonize ERα function as a transcription factor. ERα is encoded by the ESR1 gene, which itself is a target of ERα mediated transcription. When activated by estrogen, ERα binds to the ESR1 promoter, repressing new synthesis of ERα protein. Estrogen binding also induces pathways that lead to degradation of ERα protein. This negative feedback loop is finely tuned to natural levels of estrogen and results in natural levels of growth. In breast cancer, the system is thrown off its natural course such that increased levels of ERα induce levels of cell growth that can lead to cancer. Thus, both genetic changes to the ESR1 promoter, ERα protein degradation, and biochemical changes in estrogen metabolism can effectively cause changes in cell growth rates, which can be seen as the 'fitness' of a cancer cell. Predicting cancer cell growth in this system raises a conceptual multilevel simulation problem, because the molecular aspects of this model need to compute the biochemistry in a way that influences growth rates at the cellular level, without resetting growth at each cell division. We present progress towards addressing this simulation challenge in pure mass-action models, which we implemented using the Evolvix model description language. We found that such models can be constructed in more than one way. We explored some candidate model properties that could aid efforts to develop abstractions for more efficiently simulating the common multi-level modeling problems behind many important biological questions. These efforts are ongoing and aim to find efficient ways of encoding and exploring such models in silico. In particular, we are investigating how architecting a new compiler for a general-purpose programming language for biology could improve the efficiency of analyzing the dynamic multilevel simulation scenarios that characterize many questions in EvoSysBio. Progress can be followed at http://evolvix.org. Estrogen binding also induces pathways that lead to degradation of ERα. This negative feedback loop is finely tuned to natural levels of estrogen and results in natural levels of growth. In breast cancer, the system is thrown off its natural course such that increased levels of ERα induce levels of cell growth that lead to cancer. Thus, genetic changes to the ESR1 promoter, ERα protein degradation, and biochemical changes in estrogen metabolism can effectively change the rate of cell growth, which can be seen as the 'fitness' of a cancer cell.
Model M4: Over-Separated
Separate for these 4 cell types (Lo0↔ Lo1↔ Hi2 ↔ Hi3 ):
• Set Counts of PreGrowCells and PreDiviCells
• ERα Element Counts in all PreGrow, PreDivi • Loss of ERα cell locations, but cell type is kept • Change Set and El counts at LifeCycleEvents
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The Nesting Problem
Why is it so difficult to consider biochemical changes in the context of replicating cells? 
Discussion
ERα is a key regulator in normal physiology, as well as disease development. To improve our understanding of the ERα regulation system, we need to model more of what ERα does in the cell. This includes dimerization, binding to estrogen response elements in target genes, and activating or repressing gene expression. The impact of ERα on cell growth requires better multi-level models for understanding cancer. How to simulate these models is an active area of research [14] [15] [16] [17] , and of crucial importance for the EvoSysBio goal of constructing fitness landscapes 6-8 .
Modeling
Our basic models track the relative molecular abundance of the ERα transcription factor. When overabundant, ERα can stimulate cell growth and cells become cancerous 1 .
We use the Evolvix modeling language 9 (Free Prototype 0.3.1). It allows us to efficiently explore diverse models and focus on the biology instead of model construction. It simulates pure mass-action systems observing amounts of interacting parts. It uses known methods 9-12 to simulate Continuous-Time Markov Chains using various methods. Mathematical models' importance for the study of dynamic, multi-level, biological systems has grown, but models currently rarely span more than one level.
Biochemistry affects growth rates of cells yet many biochemical models ignore population consequences. In turn, most population models ignore biochemical details that affect growth and are changed by mutations. 5 EvoSysBio fitness landscapes require full integration. [6] [7] [8] Main Question 
Modeling Conclusions
M1 & M2 time series match published simulations 1 fitted to observed relative molecular amounts ( Fig.1-2 ). M3 cells quickly switch between 2 biochemical states with longer / shorter waits for cell division. Passing through a rare brief transient state (Fig.3, pink) shared by new cells is enough to force mixing of both life history cycles; unlikely for mitotic cancer cells, maybe relevant for strong anisogamy models. M4 has 4 complete life-history cycles for all 4 ERα counts allowed in its Lo / Hi growth cells (Fig.5 ). These could be independent, but are linked here in ERα incr-/decreasing transitions (Fig.6 ). Cell and ERα counts change separately. 
